Agilent Technologies

Agilent Technologies

Yahoo Finance • yesterday

Stock futures lower after Wall Street selloff

[Wall Street sign in Lower Manhattan, NYC] georgeclerk Stock index futures were lower on Thursday after U.S. equities closed deep in the red on Wednesday as Treasury yields spiked and markets priced in further rate hikes in the year. Dow... Full story

Yahoo Finance • 2 days ago

Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation

Key Points Interested in Agilent Technologies, Inc.? Here are five stocks we like better. Growth is accelerating: Agilent cited improving end markets, China, market-share gains and LC/GC instrument replacement cycles as key drivers. Manag... Full story

Yahoo Finance • 3 days ago

Capitalize on the Label-Free Detection Market Shift: Track How Danaher, Sartorius, Agilent, Bruker and Revvity Are Disrupting R&D ROI and Reshaping Global Revenue Through 2030

Company Logo AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows. Dublin, Sept. 22, 2026 (GLOBE... Full story

Yahoo Finance • 4 days ago

Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control

New CE-IVD-labeled systems and software bring established TapeStation technology to regulated clinical laboratory workflows SANTA CLARA, Calif., September 21, 2026--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the... Full story

Yahoo Finance • 6 days ago

Agilent (A) Wants Pathology Labs To Go Digital, 540 Slides At A Time

On September 4, Agilent Technologies (NYSE:A) launched a slide scanner in the United States that can hold up to 540 glass slides at once. The Agilent S540MD has FDA clearance and targets labs buried in samples and eyeing AI-assisted workfl... Full story

Yahoo Finance • 10 days ago

Global Mass Spectrometry Market to Reach USD 10.78 Billion by 2031, Driven by Biologics, Precision Medicine and LC-MS/MS Adoption

Company Logo The global mass spectrometry market is projected to grow from USD 7.07 billion in 2026 to USD 10.78 billion by 2031, at an 8.8% CAGR. Growth is driven by precision medicine, biologics, multi-omics research, regulatory bioanal... Full story

Yahoo Finance • 15 days ago

Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead

Company Logo The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision medicine, drug discovery, biomarker dev... Full story

Yahoo Finance • 16 days ago

Sector Update: Healthcare Stocks Softer Late Afternoon

Healthcare stocks were lower late Wednesday afternoon with the NYSE Healthcare Index and the State S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 21 days ago

Ionis Pharmaceuticals falls after Pelacarsen fails key Phase 3 heart trial

* Ionis Pharmaceuticals (IONS [https://seekingalpha.com/symbol/IONS]) announced on Friday that partner Novartis' pelacarsen [https://seekingalpha.com/pr/20641535-ionis-partner-novartis-announces-lp-a-horizon-phase-3-topline-results-for-p... Full story

Yahoo Finance • 21 days ago

Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share

Company Logo The global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with a 34% share, while Asia Pacific is the fastest-growing region at 15.5%;... Full story

Yahoo Finance • 29 days ago

A Q2 Deep Dive: Product Momentum, China Recovery, and Operating Leverage Drive Results

A Q2 Deep Dive: Product Momentum, China Recovery, and Operating Leverage Drive Results Life sciences tools company Agilent Technologies (NYSE:A) announced better-than-expected revenue in Q2 CY2026, with sales up 8.1% year on year to $1.88... Full story

Yahoo Finance • 29 days ago

Agilent Technologies (A) Has Investors Looking Closer After Its Latest Update

Agilent Technologies (A) is back in focus after raising its fiscal 2026 revenue guidance to a range of $7.49b to $7.51b, alongside fresh fourth quarter projections tied to its latest earnings release. The raised 2026 guidance and stronger... Full story

Yahoo Finance • 30 days ago

Agilent forecasts FY2026 revenue of $7.49B-$7.51B and EPS of $6.18-$6.21 as China returns to 9% growth

Earnings Call Insights: Agilent Technologies (A) Q3 2026 MANAGEMENT VIEW * "We delivered an excellent third quarter with strong performance on both the top and bottom lines." (CEO, President & Director Padraig McDonnell) "For the third... Full story

Yahoo Finance • 30 days ago

Stocks making the biggest moves after hours: Nvidia, Salesforce, CrowdStrike, Urban Outfitters and more

Check out the companies making headlines in after-hour trading. Nvidia — The artificial intelligence darling rose 4% after beating expectations on both lines in the second quarter and reporting that revenue more than doubled. Nvidia earned... Full story

Yahoo Finance • 30 days ago

Agilent Technologies (A) Q3 Earnings and Revenues Top Estimates

Agilent Technologies (A) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.37 per share a year ago. These figures are adjusted for non-recurring it... Full story

Yahoo Finance • 30 days ago

Agilent (NYSE:A) Posts Better-Than-Expected Sales In Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations

Agilent (NYSE:A) Posts Better-Than-Expected Sales In Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations Life sciences tools company Agilent Technologies (NYSE:A) reported revenue ahead of Wall Street's expectations in Q2 CY2026, w... Full story

Yahoo Finance • 30 days ago

Agilent Technologies beats estimates, raises guidance on strong demand

Investing.com -- Agilent Technologies Inc (NYSE:A) reported third-quarter results that exceeded analyst expectations and raised its full-year guidance, driven by improving end markets and strong product demand. Shares rose 3% in after-hour... Full story

Yahoo Finance • 30 days ago

Agilent Technologies Non-GAAP EPS of $1.62 beats by $0.13, revenue of $1.88B beats by $40M

* Agilent Technologies press release [https://seekingalpha.com/pr/20631328-agilent-reports-third-quarter-fiscal-year-2026-financial-results] (A [https://seekingalpha.com/symbol/A]): Q3 Non-GAAP EPS of $1.62 beats by $0.13. * Revenue of... Full story

Yahoo Finance • 30 days ago

Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results

Delivers strong Q3 results and raises FY26 revenue growth, margin expansion, and non-GAAP EPS(4) guidance on continued operational momentum Third-quarter fiscal year 2026 Revenue of $1.88 billion for the third quarter ended July 31, 2026... Full story

Yahoo Finance • last month

Is Avantor a Buy as Revival Progress Faces Persistent Margin Pressure?

Avantor, Inc. AVTR is showing clearer signs that its Revival program is improving execution. VWR returned to growth sooner than expected, Bioscience & Medtech Products orders strengthened and management raised its 2026 outlook. The recove... Full story